Among potentially modifiable age-related conditions linked to dementia, Alzheimer's
disease (AD), and late-life cognitive disorders, age-related hearing impairment (ARHI)
or presbycusis is the most widely diffused sensory disorder and one of the principal
causes of chronic disability in older adults (Gates and Mills, 2005). The impairments
of peripheral (sensory or strial) and central (predominantly neural) auditory pathways,
diagnosed with different procedures, are often variously imbricated in determining
ARHI, with mixed clinical findings (Gates and Mills, 2005). A growing body of epidemiological
evidence linking ARHI with late-life cognitive disorders (Panza et al., 2015a) suggested
the potential for correcting hearing loss so that elders can function better also
from a cognitive point of view with appropriate treatment.
ARHI is also a substantial marker for frailty in older age, another age-related clinical
condition for identifying older persons at elevated risk for numerous adverse health
outcomes such as falls, institutionalization, hospitalization, disability, and death
(Rodríguez-Mañas, 2013). Frailty is as a multidimensional syndrome characterized by
a nonspecific state of vulnerability, reduced multisystem physiological reserve, and
decreased resistance to stressors (Rodríguez-Mañas, 2013). Although there is no consensus
regarding the operational definition of frailty, in general, two are the most frequently
used approaches: the first is the physical or “phenotypic” model of frailty, while
the second is based on deficit accumulation, measured with the so called frailty indexes,
and defined as an accumulation of health-related deficits and disorders (Rodríguez-Mañas,
2013). However, also psychological, cognitive and social factors are part of this
multidimensional syndrome, with great influence on its definition and treatment. Cognition
has already been suggested as a possible component of frailty with increased risk
of adverse outcomes. Therefore, the prevention of cognitive-related adverse outcomes
including delirium (Eeles et al., 2012) and late-life cognitive disorders (Robertson
et al., 2013; Panza et al., 2015b) may be possible also through frailty prevention.
Peripheral age-related hearing impairment, Alzheimer's disease, and cognition
In the USA, ARHI is even more prevalent among older adults than previously reported,
with the ARHI prevalence that approximately doubles every decade of life from the
second through to the seventh decade (Quaranta et al., 2015). At early stage, ARHI
typically affects audibility of the higher frequencies (6000 and 8000 Hz), interfering
with regular speech comprehension in both quiet and noise, and spreading to the mid
and low frequencies over time. Part of the hearing problems are not related to the
peripheral deficit of the auditory system but to the central auditory processing (CAP)
dysfunction. Subjects with this condition have considerable difficulty in understanding
speech in presence of a background noise or in reverberant rooms, but no problem in
a quiet environment. Both peripheral and central auditory dysfunctions are therefore
relevant to assess a possible influence of ARHI on late-life cognitive disorders.
Over two decades ago, a review article with also original findings summarized the
first 25 years of research on possible associations between hearing impairment and
cognitive dysfunction reviewing a relevant number of reports (Gennis et al., 1991).
The cumulative evidence coming from this first series of studies suggested a strong
link between peripheral ARHI and cognitive impairment or decline in demented or institutionalized
patients, while there was no association in nondemented older subjects (Gennis et
al., 1991). More recently, a case-control report on AD patients from a tertiary center
(Gold et al., 1996) and a number of cross-sectional (Gussekloo et al., 2005; Lin,
2011) and longitudinal population-based studies (Lin et al., 2004, 2011, 2013; Valentijn
et al., 2005; Wallhagen et al., 2008; Gallacher et al., 2012; Kiely et al., 2012)
(Table 1) confirmed the interplay among peripheral auditory dysfunction and AD, dementia,
and cognitive disorders in older age, with a single exception in a 2-year follow-up
of the Australian Longitudinal Study of Aging (Anstey et al., 2001). However, a weak
association between hearing loss and memory decline was found in a re-evaluation of
the same sample in a longer follow-up of 8 years (Anstey et al., 2003) (Table 1).
Table 1
Principal case-control and longitudinal population-based studies of peripheral auditory
dysfunction and central auditory processing dysfunction in age-related hearing impairment
in relation to late-life cognitive decline, incident dementia and Alzheimer's disease
(AD).
References
Subjects
Assessment of auditory function
Assessment of cognition or diagnosis of dementia
Covariates
Principal findings
PERIPHERAL AUDITORY DYSFUNCTION
Anstey et al., 2001 The Australian Longitudinal Study of Aging Australia
2087 subjects aged 70–96 years
Pure-tone audiometry with portable audiometers
Similarities and DSS from WAIS-R, BNT, and NART
Age
In a 2-year follow-up, decline in hearing was not associated with decline in any cognitive
domain
Anstey et al., 2003 The Australian Longitudinal Study of Aging Australia
525 subjects, mean age 74.7 years
Pure-tone audiometry with portable audiometers
Similarities and DSS from WAIS-R, BNT, and NART
Age, gender, depressive symptoms, self-rated health, and medical comorbidities
In a 8-year follow-up, a weak association between hearing decline and memory decline
was found
Lin et al., 2004 The Study of Osteoporotic Fractures (SOF) USA
6112 women aged 69 years and older
Pure-tone audiometry with hand-held audiometers
3MS and functional status assessed with five activities: walking, climbing stairs,
preparing meals, shopping, and doing housework
Medical comorbidities, age, education level, smoking, presence of vertebral fracture,
benzodiazepine use, BMI, Lubben social network, grip strength, walking speed, and
baseline cognitive or functional status
Combined hearing and vision impairment was associated with cognitive and functional
decline after a 4-year follow-up period
Valentijn et al., 2005 The Maastricht Aging Study The Netherlands
418 subjects aged 55 years and older
Pure-tone audiometry
VVLT, SCWT, CST, VFT, and LDST
Age, sex, education level, baseline cognitive performance, change in vision or hearing,
and baseline vision or hearing
A change in auditory acuity predicted change in memory performance, and auditory acuity
at baseline predicted change in the mean score of the first two SCWT cards and the
LDST in a 6-year follow-up
Wallhagen et al., 2008 The Alameda County Study USA
2002 subjects aged 50–94 years
Self-report
A self-report measure of cognitive functioning
Chronic conditions, age, sex, and education level
In a 5-year follow-up, a relationship between baseline hearing impairment and subsequent
poorer cognitive function was found in both existing and new cases of cognitive impairment
Lin et al., 2011 The Baltimore Longitudinal Study of Aging USA
639 subjects aged 36–90 years
Pure-tone audiometry
Diagnoses of dementia and AD using DSM-III-R and NINCDS-ADRDA criteria
Sex, age, race, education level, diabetes, smoking, hypertension, and hearing aid
use
During a median follow-up of 11.9 years, baseline hearing loss was independently associated
with incident all-cause dementia
Gallacher et al., 2012 The Caerphilly cohort United Kingdom
1057 men mean age 56.2 years
Pure-tone audiometry.
Diagnoses of dementia and AD using DSM-IV and NINCDS-ADRDA criteria. MMSE, CAMCOG,
AH4, and CRT
Age, social class, anxiety, and premorbid cognitive ability
Over a 17-year period, auditory threshold was found to be associated with incident
dementia and cognitive decline. An additional effect of change in auditory threshold
over 8 years was found for nonvascular dementia
Kiely et al., 2012 The Dynamic Analyses to Optimize Aging Project Australia
4221 subjects aged 50–103 years
Pure-tone audiometry.
MMSE
Age, sex, diabetes, stroke, hypertension, visual impairment, smoking status, workplace
noise exposure, and high-frequency audiometric noise notches
Cognitive impairment and hypertension were independently associated with lower levels
and accelerated declines of peripheral hearing, and incidence of cognitive impairment
was also associated with poorer hearing function in a 11-year follow-up
Lin et al., 2013 The Health ABC Study USA
1984 subjects mean age: 77.4 Years
Pure-tone audiometry.
3MS and DSS
Age, sex, race/ethnicity, education level, study site, smoking status, hypertension,
diabetes mellitus, and stroke history
In a 6-year follow-up, hearing loss was independently associated with accelerated
cognitive decline and incident cognitive impairment
CENTRAL AUDITORY PROCESSING DYSFUNCTION
Gennis et al., 1991 USA
112 community-dwelling adults aged 60 years and older
Pure-tone audiometry and SPIN
WMS and JCST
Age and sex
In a 5-years follow-up, no evidence that peripheral or central hearing impairment
predicted cognitive decline was found
Gates et al., 1996 Framingham Heart study USA
Population-based, 1662 people aged 63–95 years
Pure-tone audiometry and SSI-ICM
MMSE and diagnosis of dementia and AD using NINCDS-ADRDA criteria
Age and education level
In a 6-year follow-up, CAP dysfunction in one ear increased the risk of subsequent
dementia or cognitive decline; CAP deficit present in both ears doubled the risk
Gates et al., 2002 Framingham Heart study USA
Population-based, 740 people aged 63–95 years
Pure-tone audiometry and SSI-ICM
MMSE and diagnosis of probable AD using NINCDS-ADRDA criteria
Age, gender, education level, APOE e4 allele presence, and hearing level
In a 8-year follow-up, CAP dysfunction presence was associated with a 10 times higher
risk for developing AD
Gates et al., 2011 The Adult Changes in Thought Study USA
Population-based, 274 people aged 71–96 years
Pure-tone audiometry, SSI-ICM, DSI test, and DDT
CASI and diagnoses of dementia and AD using DSM-IV and NINCDS-ADRDA criteria
Education level
In a 3-year follow-up, severe CAP dysfunction strongly predicted the risk of a subsequent
diagnosis of AD
Idrizbegovic et al., 2013 Sweden
Case-control, 70 participants aged 50–80 years with MCI or AD and SMC
Pure-tone audiometry, SPIN, and DDT
MMSE, MCI diagnosis, and diagnoses of dementia and AD using DSM-IV and NINCDS-ADRDA
criteria
None
In a 1.5-year follow-up, CAP showed a significant decline in the AD group compared
with the controls/SMC subjects (left ear)
DSS, Digit Symbol Substitution subscale; WAIS-R, Wechsler Adult Intelligence Scale-revised;
BNT, Boston Naming Test; NART, National Adult Reading Test; 3MS, modified version
of Mini-Mental State Examination; BMI, body mass index; VVLT, Visual Verbal Learning
Test; SCWT, Stroop Color Word Test; CST, Concept Shifting Task; VFT, Verbal Fluency
Test; LDST, Letter-Digit Substitution Test; DSM-III-R, Diagnostic and Statistical
Manual of Mental Disorders, third edition, revised; NINCDS-ADRDA, National Institute
of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease
and Related Disorders Association; MMSE, Mini-Mental State Examination; DSM-IV, Diagnostic
and Statistical Manual of Mental Disorders, Fourth Edition; CAMCOG, Cambridge Cognitive
Examination; AH4, Alice Heim test; CRT, 4-choice reaction time task; SPIN, Speech
perception in noise; WMS, Wechsler Memory Scale; JCST, Jacobs Cognitive Screening
Test; SSI-ICM, Synthetic sentence identification with either an ipsilateral competing
message; APOE, apolipoprotein E; DSI, dichotic sentence identification; DDT, dichotic
digits test; CASI, Cognitive Abilities Screening Instrument; DSM-IV, Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition; MCI, mild cognitive impairment;
SMC, subjective memory complaints.
Central auditory processing dysfunction, mild cognitive impairment, and Alzheimer's
disease
Age-related decline in CAP appeared not to be an isolated condition, but an entity
with a multifactorial nature associated to age- and/or disease-related brain and auditory
changes (Gates and Mills, 2005). In fact, CAP dysfunction increases with age (Gates
and Mills, 2005), but given the increased incidence of both peripheral ARHI and cognitive
impairment in late life, the interpretation of central auditory tests may be difficult.
In particular, in the early phase of cognitive decline, the differential impact of
the two types of auditory deficits on late-life cognitive disorders may be not easy
to determine. Several existing studies mostly focused on the impact of peripheral
auditory deficit on late-life cognition, while studies on the link between CAP dysfunction
and mild cognitive impairment (MCI) or AD are sparse (Gennis et al., 1991; Kurylo
et al., 1993; Gates et al., 1996, 2002, 2008, 2010, 2011; Idrizbegovic et al., 2011,
2013).
Several cross-sectional case-control (Kurylo et al., 1993; Idrizbegovic et al., 2011)
and two population-based studies (Gates et al., 2008, 2010) suggested a strong involvement
of CAP dysfunction in MCI (Idrizbegovic et al., 2011), dementia (Gates et al., 2010),
and AD (Kurylo et al., 1993; Gates et al., 2008; Idrizbegovic et al., 2011). In particular,
findings from the Adult Changes in Thought (ACT) Study suggested that CAP disorders
may be associated with executive dysfunction in older subject with and without memory
loss and dementia (Gates et al., 2010). Therefore, executive control function may
be a key factor in the speech-based behavioral tasks evaluating CAP dysfunction because
lesions of the central auditory pathway are infrequent in early AD (Kurylo et al.,
1993).
A few longitudinal case-control (Idrizbegovic et al., 2013) and population-based studies
(Gates et al., 1996, 2002, 2011) suggested that CAP dysfunction in ARHI may be central
in determining an increased risk of cognitive decline and incident dementia or AD
(Gates et al., 1996), and AD (Gates et al., 2002, 2011) (Table 1). Therefore, deficit
in CAP could be an early marker of MCI or AD, with a “gradient” existing in CAP disorders
among subjects with subjective memory complaints, MCI, and early AD (Idrizbegovic
et al., 2011).
Age-related hearing impairment-dementia link and frailty
Some factors may be involved in causal mechanistic pathways linking ARHI and cognition,
while other factors may constitute shared pathological processes or etiological pathways
underlying both ARHI and cognitive disorders in late life. Cognitive testing may be
confounded by ARHI in association with poor verbal communication. However, some studies
used also nonverbal cognitive tests or were insensitive to the exclusion of subjects
with serious hearing loss from the analyses (Anstey et al., 2003; Lin et al., 2013),
so not supporting the hypothesis that miscommunication in hearing loss should impair
cognitive testing. Furthermore, in older subjects with subclinical cognitive impairment
may occur an overdiagnosis of peripheral ARHI, although audiometric testing appeared
to be reliable also in patients with early dementia.
Evidence coming from epidemiological (Fratiglioni et al., 2000; Wilson et al., 2007)
and neuropathological studies (Bennett et al., 2006) suggested that social isolation
and loneliness, caused by communication impairments in older subjects with ARHI, may
lead to cognitive decline and AD. Moreover, also the cognitive reserve concept, often
conditioned by communication defects, may account for the link between ARHI and cognition.
Cognitive/brain reserve appears to be a buffer against the functional impairments
caused by accumulating age-related brain changes or AD-related pathology, so acting
as a modulator of the interplay between neuropathology and cognitive outcomes. Increased
cognitive load to help compensate auditory processing may reduce the neural resources
available to other cognitive processes such as working memory and perceptual speed,
increasing the deleterious effects of AD pathology and revealing the earlier clinical
symptoms of dementia (Boyle et al., 2008). Furthermore, a key link between communication
difficulties, social isolation, and cognitive decline is the reduced capacity to participate
in mentally stimulating activities. In fact, cognitive reserve acts as a buffer via
engaging in cognitively stimulating behaviors within an enriched environment, so enhancing
neuroplasticity, Furthermore, while AD-related neuropathology is absent in the peripheral
auditory pathways (Sinha et al., 1993), peripheral ARHI may contribute to loss of
gray matter volume in primary auditory cortex (Peelle et al., 2011), accelerated rates
of decline in regional brain volumes in the right temporal lobe and whole brain volume
(Lin et al., 2014), and variation in the integrity of central auditory white matter
tracks (Chang et al., 2004). AD-related neurodegeneration may be also involved in
peculiar damage of central auditory nuclei required for higher-order auditory processing
(Parvizi et al., 2001). However, more serious effects may be caused by damage to higher-order
cortical areas involved in language processing (Kurylo et al., 1993), so not excluding
a shared neuropathological origin underlying both ARHI and AD/dementia.
Among possible confounders, common pathological processes, or shared etiological pathways
linking ARHI and cognition, frailty syndrome could have a central role. In fact, ARHI
may be also a strong indicator for both the most widely diffused models of frailty.
In some operational definitions and frailty indexes, ARHI is one of the suggested
components of frailty (Frailty Index-Comprehensive Geriatric Assessment, Groningen
Frailty Indicator, and Puts model) (Panza et al., 2015a) and it may predict functional
decline or incident falls in older adults (Lin and Ferrucci, 2012), some of the health-related
adverse outcomes linked to frailty. Among potentially modifiable risk factors, there
is a growing body of evidence about the impact of several operational definitions
of frailty on late-life cognitive disorders (Robertson et al., 2013; Panza et al.,
2015b). In particular, an international consensus group has recently proposed the
clinical label “cognitive frailty” for describing the simultaneous presence of both
physical frailty and cognitive impairment in nondemented older individuals (Kelaiditi
et al., 2013), representing also a possible precursor of neurodegenerative processes
and AD. Epidemiological studies strongly suggested that physical frailty may be associated
with incident AD and MCI, nonAD dementias, vascular dementia (VaD), AD-related neuropathology,
and cognitive impairment and decline in late life (Robertson et al., 2013; Solfrizzi
et al., 2013; Panza et al., 2015b), so also validating cognitive frailty as a new
clinical condition. Several factors and diseases associated with physical frailty
are also related to cognitive impairment, including nutritional factors, metabolic
disorders, inflammatory markers, hormones, diabetes mellitus, congestive heart failure,
and stroke (Robertson et al., 2013; Panza et al., 2015b), suggesting an underlying
and shared pathogenesis probably linked to vascular determinants. In fact, in 2006,
the term “cognitive frailty” was firstly used to indicate a specific state of cognitive
vulnerability in MCI and related entities exposed to vascular risk with a consequent
elevated progression to dementia (Panza et al., 2006). Physical frailty has been proposed
also as a prodromal stage of VaD (Robertson et al., 2013; Solfrizzi et al., 2013).
This could be therefore a further common pathway explaining the ARHI-frailty-cognition
interplay given that another neurobiological process such as vascular disease or shared
vascular factors may cause ARHI, frailty, and dementia.
Conclusions and future directions
In recent years, there has been growing attention on the possible correlations between
sensorial abnormalities and late-life cognitive disorders. Epidemiological evidence
is mainly focused on peripheral auditory disorders and cognition, but in longitudinal
population-based studies both peripheral and CAP dysfunctions appear to be associated
with incident cognitive impairment and AD and accelerated cognitive decline. While
some randomized controlled trials (RCTs) showed improvement in cognitive function
or global measures of change in hearing-aid users not cognitively impaired (Mulrow
et al., 1990) or with dementia (Allen et al., 2003), determining whether treating
hearing loss could delay cognitive decline and dementia remains an open issue. In
fact, RCTs with more representative cohorts and technology (i.e., digital hearing
aids or cochlear implants), longer follow-up periods, and estimating the effects of
hearing rehabilitative interventions on cognitive and global functioning have never
been performed (Lin, 2012). At present, use of amplification can be an effective tool
for minimizing the perceived disability of older adults and reducing the AD caregiver
burden by enhancing the communication abilities of the patients (Palmer et al., 1998).
However, hearing aids alone could be not enough to properly manage ARHI, and interventions
should be broader, incorporating also concerted counseling, environmental accommodations,
and rehabilitative hearing training. Cognition and dementia are causally linked to
frailty, and ARHI is also a component of frailty included in several operational definitions.
Therefore, frailty could have an important impact in the prevention of late-life cognitive
disorders, with nutrition and physical exercise as factors potentially affecting frailty
status in advanced age (Clegg et al., 2013). Further investigation on the role of
vascular risk on the ARHI-frailty-cognition interplay is warranted to better understand
causal mechanisms. Overlaps or interactions among the contributing factors could be
investigated supplementing speech-based behavioral measures of CAP with nonbehavioral
measures based on electrophysiological studies, and structural, spectroscopic, and
functional neuroimaging to detect shared neurobiological markers of ARHI and cognitive
decline.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial
or financial relationships that could be construed as a potential conflict of interest.